Any Experience with: Alpha-Glucosidase Inhibitors &/or Sodium-Glucose Transporter-2 Inhibitors?

Anyone have experience with either of these? I'm especially interested if any NON-diabetics with T have tried these.

• Alpha-glucosidase inhibitors &/or
  
• Sodium-Glucose Transporter-2 Inhibitors?

I noticed that T grows loud after eating (even after low carb/low sugar meals) and I wonder if I can better control/minimize blood sugar and insulin, perhaps the volume of T will be reduced. (And/or maybe I can indulge in eating an orange or apple).

These two Type 2 diabetes drugs work differently than other Type 2 diabetes drugs in that they reduce blood sugar (and therefore reduce the need for the body to create insulin) whereas other Type 2 diabetes drugs stimulate insulin production.

• Alpha-glucosidase inhibitors – Acarbose (Glucobay).
  • Alpha-glucosidase inhibitors are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar). Carbohydrates are normally converted into simple sugars (monosaccharides), which can be absorbed through the intestine. Hence, alpha-glucosidase inhibitors reduce the impact of carbohydrates on blood sugar.
    
  • https://en.wikipedia.org/wiki/Alpha-glucosidase_inhibitor

• Sodium-Glucose Transporter-2 Inhibitors – Forxiga (dapagliflozin), Invokana (canagliflozin) and Jardiance (empagliflozin).
  • Sodium glucose co-transporter (SGLT) inhibitors are a new class of drugs which are used in the pharmacotherapy of Type-II diabetes, which happens to be a major risk factor for developing both micro as well as macro-vascular complications. These drugs inhibit the glucose reabsorption [by the kidneys back into the blood] by inhibiting SGLT, which exhibits a novel and promising mechanism of action by promoting the urinary glucose excretion hence providing a basis of therapeutic intervention.
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606572/